Analysis of the mechanisms for biological activities of thymidine phosphorylase

胸苷磷酸化酶生物活性机制分析

基本信息

  • 批准号:
    12670144
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

2-Deoxy-D-ribose (2dR) is one of metabolites of thymidine With thymidinephosphorylase (TP). We reported that 2dR has angiogenic activity before. In 2000 we found that 2deoxy L-ribose (21R), optical isomer of 2dR, can inhibit TP or 2dR induced tube formation of endotherial cells, migration of bovine aortic endotherial cells and anigogenesis in rat corneal assay and mouse dorsal air sac method. In 2001 we found that 21R can inhibit TP induced tumor growth in nude mouse xenograft model and metastasis in a liver metastasis model of mouse.These results indicated that some molecule that can recognize the molecular structure of 2dR may play important roles in the biological effect of 2dR. Furthermore 21R or analog of 21R can be a new type ahti-cancer drug.We investigated the mechanism of inhibitory effect with TP arid 2dR hypoxia induced apoptosis. 2dR could inhibit the stabilization of HIFla and the activation of p38 (MAP kinase) under hypoxic conditions. Now we are trying to find out the molecule that can directly interact with 2dR.We produced TP knockout mouse (TPKO) and TP / uridine phosphorylase (UP) double knock out mouse (TP/UPKO). UP is another molecule that can degrade thymidine. These knock out mice is fertile, morphologically normal and no signs of weight loss. Thymidine degradation activities were low in all organs except for liver of UPKO, in liver of TPKO and in all organs of TP/UPKO. Thymidine concentration in serum was 2times and 5times higher in TPKO and TP/UPKO respectively. In 1999 Nishino et al. reported that TP is a cause of MNGIE (Mitochondrial Neurogastrointestional Encephalomyopathy). We could detect no significant change as MNGIE in muscle of lOmonth-old mice, however we found the high intensity image in T2 of MRI in the brain of TP/UPKO. That may indicate TP/UPKO is useful as a model animals with encephalopathy
2-脱氧-D-核糖(2dR)是胸腺嘧啶核苷与胸苷磷酸化酶(TP)的代谢产物之一。我们以前报道过2dR具有血管生成活性。2000年,我们在大鼠角膜实验和小鼠背部气囊法中发现,2dR的光学异构体--2脱氧L核糖(21R)能抑制TP或2dR诱导的血管内皮细胞管形成、牛主动脉内皮细胞迁移和致畸作用。2001年,我们发现21R能够抑制茶多酚诱导的裸鼠移植瘤生长和小鼠肝转移模型的转移,提示一些识别2dR分子结构的分子可能在2dR的生物学效应中发挥重要作用。此外,21R或其类似物可能是一种新型的抗癌药物。我们研究了茶多酚和2dR缺氧诱导细胞凋亡的抑制机制。2DR可抑制缺氧条件下HIFla的稳定和p38(MAP-K)的激活。现在我们正在努力寻找与2DR直接相互作用的分子,我们培育了TP基因敲除小鼠(TPKO)和TP/尿苷磷酸化酶(UP)双基因敲除小鼠(TP/UPKO)。UP是另一种可以降解胸腺嘧啶核苷的分子。这些基因敲除的小鼠是可生育的,形态正常,没有体重减轻的迹象。除UPKO的肝脏外,TPKO的肝脏和TP/UPKO的所有器官的胸腺嘧啶核苷降解活性均较低。TPKO组和TP/UPKO组血清胸腺嘧啶核苷浓度分别是TPKO组的2倍和5倍。1999年,Nishino et al.据报道,TP是引起线粒体神经胃肠病(MNGIE)的原因之一。在1月龄小鼠肌肉中未检测到明显的MNGIE改变,而在TP/UPKO小鼠脑组织中可见MRI的T2高信号图像。提示TP/UPKO可作为脑病动物模型。

项目成果

期刊论文数量(57)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hisatsugu Goto: "Gamma Interferon-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages."Cancer Res.,. (in press).
Hisatsugu Goto:“通过人巨噬细胞中的γ激活序列样元件,γ干扰素依赖性诱导胸苷磷酸化酶/血小板衍生的内皮生长因子。”Cancer Res.,。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohno,N., Tani,A., Uozumi,K., Hanada,S., Furukawa,T., Akiba,S., Sumizawa,T., Utsunomiya,A., Arima,T. and Akiyama,S.: "Expression of functional lung resistance-related protein predicts poor putcome in adult T-cell leukemia"Blood. 98. 1160-1165 (2001)
大野,N.,谷,A.,鱼住,K.,花田,S.,古川,T.,秋叶,S.,隅泽,T.,宇都宫,A.,有马,T.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohno,N., Tani,A., Chen,Z.S., Uozumi,K., Hanada,S., Akiba,S., Ren,X.Q., Furukawa,T., Sumizawa,T., Arima,T. and Akiyama,S.I.: "Prognostic significance of multidrug resistance protein in adult T-cell leukemia"Clin Cancer Res. 7. 3120-3126 (2001)
大野N.、谷A.、陈Z.S.、鱼住K.、花田S.、秋叶S.、任X.Q.、古川T.、隅泽T.、有马T.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaharu Komatsu: "Copper transporting P-type ATPase (ATP7B) is associated with cisplatin resistance."Cancer Res.,. 60. 1312-1316 (2000)
Masaharu Komatsu:“铜转运 P 型 ATP 酶 (ATP7B) 与顺铂耐药性相关。”Cancer Res.,。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FURUKAWA Tatsuhiko其他文献

FURUKAWA Tatsuhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FURUKAWA Tatsuhiko', 18)}}的其他基金

Analysis of cooperative functions of transporters andvesicle transport system in efflux of anticancer agents
转运蛋白和囊泡转运系统在抗癌药物外排中的协同作用分析
  • 批准号:
    22501047
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Nano-scale analysis of the drug transport mechanism of MRP1
MRP1药物转运机制的纳米级分析
  • 批准号:
    17590272
  • 财政年份:
    2005
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of substrates transport mechanism and structural modification of MRP1
底物转运机制分析及MRP1结构修饰
  • 批准号:
    14570123
  • 财政年份:
    2002
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and analysis of tyrosine phosphatase CD45 interacting proteins
酪氨酸磷酸酶 CD45 相互作用蛋白的鉴定和分析
  • 批准号:
    09680653
  • 财政年份:
    1997
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了